Viemed Healthcare (VMD) Cash & Current Investments (2018 - 2026)
Viemed Healthcare (VMD) posted Cash & Current Investments of $9.8 million for Q1 2026, down 27.69% on a QoQ basis from $13.5 million in Q4 2025, and down 3.92% year-over-year from $10.2 million in Q1 2025.
Viemed Healthcare (VMD) Cash & Current Investments (2018 - 2026) Analysis & Trends
Viemed Healthcare's Cash & Current Investments history runs 9 years deep, the most recent figure standing at $9.8 million for Q1 2026.
- Quarterly Cash & Current Investments fell 3.92% year-over-year to $9.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.8 million (down 3.92% YoY) and the FY2025 annual result came in at $13.5 million, down 23.03% from the prior year.
- Cash & Current Investments was $9.8 million for Q1 2026 at Viemed Healthcare, down from $13.5 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $29.2 million in Q1 2022 and bottomed at $7.3 million in Q1 2024.
- A 5-year average of $15.0 million and a median of $12.8 million in 2023 frame the typical range for Cash & Current Investments.
- Annual changes were most pronounced in 2024 — Cash & Current Investments sank 68.96% — and 2025, when it surged 127.27%.
- Viemed Healthcare's Cash & Current Investments stood at $16.9 million in 2022, then decreased by 24.09% to $12.8 million in 2023, then jumped by 36.62% to $17.5 million in 2024, then slipped by 23.03% to $13.5 million in 2025, then decreased by 27.69% to $9.8 million in 2026.
- Business Quant data shows VMD's Cash & Current Investments at $9.8 million in Q1 2026, $13.5 million in Q4 2025, and $11.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.51 Bn | 174.21 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 128.52 Bn | 125.64 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 108.06 Bn | 98.84 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 68.04 Bn | 66.59 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn | 3.67 Bn |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.17 Bn | 1.98 Bn | 2.29 Bn |
| 7 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | 1.12 Bn |
| 8 | Smith & Nephew | 26.88 Bn | 26.30 Bn | - | 577.00 Mn |
| 9 | Koninklijke Philips | 25.42 Bn | 22.29 Bn | 2.07 Bn | 3.12 Bn |
| 10 | Viemed Healthcare | 459.99 Mn | 450.23 Mn | 42.83 Mn | 9.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.76 Mn |
| Dec 31, 2025 | 13.50 Mn |
| Sep 30, 2025 | 11.12 Mn |
| Jun 30, 2025 | 20.02 Mn |
| Mar 31, 2025 | 10.16 Mn |
| Dec 31, 2024 | 17.54 Mn |
| Sep 30, 2024 | 11.35 Mn |
| Jun 30, 2024 | 8.81 Mn |
| Mar 31, 2024 | 7.31 Mn |
| Dec 31, 2023 | 12.84 Mn |
| Sep 30, 2023 | 10.08 Mn |
| Jun 30, 2023 | 10.22 Mn |
| Mar 31, 2023 | 23.54 Mn |
| Dec 31, 2022 | 16.91 Mn |
| Sep 30, 2022 | 21.48 Mn |
| Jun 30, 2022 | 21.92 Mn |
| Mar 31, 2022 | 29.25 Mn |
| Dec 31, 2021 | 28.41 Mn |
| Sep 30, 2021 | 26.87 Mn |
| Jun 30, 2021 | 31.15 Mn |